Life Sciences

CBD Global Sciences, Inc. (“CBD Global”), is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals.  CBD Global’s hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.  Through its wholly owned subsidiary, Strasburg Pharms, CBD Global grows and operates irrigated land in Colorado, that grows hemp with only all-natural Colorado water, soil, sun and nutrients and never sprayed with pesticides or chemicals.  Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.  The extraction/processing facility, operated by CBD Global, is located approximately 40 minutes from the farm.

Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia. 

The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.  

Chemesis has facilities in both Puerto Rico, California and continues to expand its capabilities. The Company is positioned to win additional licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage. 

Citation Growth Corp. is a well-established high quality cannabis producer in North America, owning licensed cultivation property in Nevada, Washington, California, and British Columbia. Citation Growth Corp. pairs premier seed genetics and organic growing techniques, with plans to utilize and expand its proprietary growing technology/techniques to all its facilities and operations. The end goal is to become a true Multi-State Operator (MSO) that is fully integrated from seed to sale.

The Issuer is in the business of cannabis cultivation, production and dispensaries. The Issuer also has a patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency.